.
To add to the growth slowing point for Q2 '19 as of yesterday, 9 of the S&P 500 companies have reported and aggregate EPS YoY growth is -25%... that's negative 25%! Fair few companies to go, but something to pay close attention too. JC
-->
.
To add to the growth slowing point for Q2 '19 as of yesterday, 9 of the S&P 500 companies have reported and aggregate EPS YoY growth is -25%... that's negative 25%! Fair few companies to go, but something to pay close attention too. JC
Thank-you for this.
It will take some time to go through all the stocks but I shall update from time to time. Your method is different and the software not interactive so no comment on technique.
For the time being I shall just mention some that I follow:
TAC Transalta. Sold 2 April which was the High and 19 March after the spike up. Considering re-entry as per your recommendation. This stock was Much higher a few years ago.
MSEX Middlesex Water. Looked at this a few months ago but cannot find date for moment.
Mid April was time to buy. No position.
A lot of those on your list have been eliminated for fundamental reasons. Relative value can be found elswhere in stocks I shall post later.
ENB (Enbridge NYQ & TSE same symbol) short term resistance at 37.50ish went ex-divi 15 May both of which reduce my interest risk/reward. However in 2016 I bought USD 40$ and sold 45$ so there's room up there. Strong support at 30$ and that would be my preferred entry point or close to it. Last year bought 32$ sold 35$.
No other short term technical indicators.
Stocko likes it except for price to cashflow. Good gearing.
Brokers think it is undervalued with 11 to 15% upside.
TCP (TC Pipelines NYQ).
This one is motoring and it may be too late for the move. Ex-divi 2 May. Brokers think it is overvalued. Stocko sees value. Gearing high.
Support at 35.75$
One to buy on the retracement.
Good price to cashflow.
There's still significant supply coming to the market with ENB, so I wouldn't be looking to open a position here. TCP showing strength, although I'd expect short-term testing action. JC